Full history for every metric is available with a Kvantra account
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 123 | 191 | 202 | 145 | 136 | 171 | 197 |
| Operating profit | €m | 8.72 | 4.25 | |||||
| Net profit | €m | 5.8 | 15.9 | 15.7 | -15.8 | -5.0 | -15.0 | -3.4 |
| EPS reported | € | -0.81 | -0.20 | |||||
| Operating cashflow per share | € | 0.37 | 0.31 | |||||
| Capex per share | € | 0.11 | 0.21 | |||||
| FCF per share | € | 0.26 | 0.23 | |||||
| Free cash flow | €m | 4.86 | 4.96 | |||||
| Net debt | €m | 57.7 | 63.1 | |||||
| Book value equity | €m | 61.3 | 66.4 | |||||
| Book value per share | € | 3.27 | 3.02 | |||||
| Number of shares | m | 18.75 | 22 | |||||
| DPS (TTM paid) | € | 0.01 | 0.00 |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.05 | 2.09 | |||||
| P/S LTM | x | 0.73 | 0.70 | |||||
| P/FCF LTM | x | 25.87 | 27.99 | |||||
| EV/EBITDA LTM | x | -68.58 | 24.40 | |||||
| EV/Sales LTM | x | 1.08 | 1.02 | |||||
| Earnings Yield LTM | % | -11.94% | -2.07% | |||||
| FCF Yield | % | 3.86% | 3.57% | |||||
| Quality | ||||||||
| ROE | % | -24.47% | -5.37% | |||||
| ROIC | % | 5.60% | 2.59% | |||||
| Operating margin | % | 5.10% | 2.16% | |||||
| Gross margin | % | 22.05% | 25.55% | |||||
| FCF/Sales | % | 2.84% | 2.51% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +25.71% | +36.65% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.09% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | -0.78% | -3.18% | |||||
| FCF/Debt | x | 0.07 | 0.07 | |||||
| Net Debt/EBITDA | x | -21.80 | 7.65 | |||||
| EBIT/Net interest | x | 2.72 | 1.31 | |||||
| Net debt/market cap | % | 45.90% | 45.53% | |||||
| Net debt/Equity | x | 0.94 | 0.95 | |||||
| Gross debt/equity | x | 1.13 | 1.04 | |||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Masterplast Nyrt. is a company primarily focused on the creation and commercialization of building supplies. Its business activities are organized across three distinct divisions: Sales, Construction, and Healthcare. Within its Sales segment, Masterplast distributes various products, including fiberglass materials, roofing membranes, and insulation foils, complemented by personalized support and bespoke services. The Construction division specializes in delivering comprehensive building solutions. Furthermore, the Healthcare unit is responsible for providing both foundational raw materials and finished goods for medical applications. The company's origins trace back to 1997, when it was founded by Balázs Ács and Dávid Tibor. Its main corporate offices are located in Sárszentmihály, Hungary.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Masterplast Nyrt. (MASTERPLAST.BD)
Based on consensus from external analysts. Not Kvantra's opinion.
Masterplast Nyrt. is a company primarily focused on the creation and commercialization of building supplies. Its business activities are organized across three distinct divisions: Sales, Construction, and Healthcare. Within its Sales segment, Masterplast distributes various products, including fiberglass materials, roofing membranes, and insulation foils, complemented by personalized support and bespoke services. The Construction division specializes in delivering comprehensive building solutions. Furthermore, the Healthcare unit is responsible for providing both foundational raw materials and finished goods for medical applications. The company's origins trace back to 1997, when it was founded by Balázs Ács and Dávid Tibor. Its main corporate offices are located in Sárszentmihály, Hungary.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free